NETO2 and nasopharyngeal carcinoma: Chen et al. found that TTN‐AS1 could expedite the proliferative, migratory, and invasive capabilities of nasopharyngeal carcinoma by targeting miR‐876‐5p/UPF1/NETO2 signaling.35